Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments

por Humbert, Marc, Canvin, Janice, Kiechle, Tamara, Lowe, Phil, Erpenbeck, Veit
Publicado 2013

Post hoc analyses of response rates to pharmacological treatments in children and adolescents with attention-deficit/hyperactivity disorder

por Coghill, David R, Newcorn, Jeffrey H, Chen, Jie, Werner-Kiechle, Tamara, Banaschewski, Tobias
Publicado 2020

Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses

por Coghill, David R., Werner-Kiechle, Tamara, Farahbakhshian, Sepehr, Bliss, Caleb, Robertson, Brigitte, Huss, Michael
Publicado 2020

Association Between Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder and Long-term Unemployment Among Working-Age Individuals in Sweden

por Li, Lin, Chang, Zheng, Sun, Jiangwei, Jangmo, Andreas, Zhang, Le, Andersson, Lars Magnus, Werner-Kiechle, Tamara, Ahnemark, Ewa, D’Onofrio, Brian M., Larsson, Henrik
Publicado 2022

Attention-deficit/hyperactivity disorder and occupational outcomes: The role of educational attainment, comorbid developmental disorders, and intellectual disability

por Jangmo, Andreas, Kuja-Halkola, Ralf, Pérez-Vigil, Ana, Almqvist, Catarina, Bulik, Cynthia M., D’Onofrio, Brian, Lichtenstein, Paul, Ahnemark, Ewa, Werner-Kiechle, Tamara, Larsson, Henrik
Publicado 2021